News about Clinical Trials

Julius Clinical Strengthens CNS and Cardiometabolic Expertise, Adds Operations in Spain and Germany

Julius Clinical has reported strong Q2 2025 growth in CNS and Cardiometabolic bookings, driven by its merger with Peachtree BioResearch Solutions and expanded operations in Spain and Germany.

Clinical Trials | 04/09/2025 | By Mrinmoy Dey |  154

Onco3R Therapeutics Secures Approval to Launch First-in-Human Trial of SIK3 Inhibitor O3R-5671

Onco3R Therapeutics is expected to start enrolling subjects for the first-in-human trial of SIK3 inhibitor O3R-5671 over the coming weeks, with dosing of the first subject anticipated later in September.

Clinical Trials | 04/09/2025 | By Dineshwori |  270

India to Reform New Drugs and Clinical Trials Rules, Halve Processing Time for Test Licences

By amending the New Drugs and Clinical Trials (NDCT) Rules, 2019, the Indian government aims to simplify the requirements and procedures for obtaining test licences and for submitting applications related to Bioavailability/Bioequivalence (BA/BE) studies.

Clinical Trials | 04/09/2025 | By Dineshwori |  121

SK bioscience Files IND for Global Phase 3 Trial of Two-Dose Varicella Vaccine

SK bioscience's Phase 3 clinical trial of SKYVaricella aims to evaluate the immunogenicity and safety of the 2-shot varicella vaccine in roughly 800 children aged 12 months to 12 years, with completion targeted by 2027.

Clinical Trials | 02/09/2025 | By Dineshwori |  136

Foresight Diagnostics Resolves Litigation with Roche, Grants Limited License for PhasED-Seq in Lymphoma

Foresight Diagnostics, a privately held cancer diagnostics company, has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Systems, resolving ongoing litigation between the parties. As part of the resolution, all claims against Foresight, its founders, and Stanford University have been dismissed with prejudice.

Clinical Trials | 01/09/2025 | By Darshana |  243

AstraZeneca's Baxdrostat Achieves Significant Blood Pressure Reduction in Phase-III Study

The BaxHTN phase-III trial showed Baxdrostat, an investigational drug developed by AstraZeneca, significantly lowered systolic blood pressure in patients with hard-to-control hypertension, achieving both statistical and clinical relevance.

Clinical Trials | 01/09/2025 | By Dineshwori |  216

Wegovy Outperforms Tirzepatide, Slashes Cardiovascular Risk by 57 Percent

Wegovy showed a significant 29 percent risk reduction for heart attack, stroke and death from any cause compared with Tirzepatide (over an average follow-up of 8.3 months for Wegovy and 8.6 months for Tirzepatide.

Clinical Trials | 01/09/2025 | By Dineshwori |  125

Amgen Partners with Veeva Systems to Drive Innovation in Clinical Trials

Veeva Systems, a leading provider of cloud-based software, data, and consulting services for the life sciences industry, has announced a strategic collaboration with biotechnology giant Amgen to advance clinical trial innovation.

Clinical Trials | 01/09/2025 | By Darshana |  218

Prometheus Laboratories Collaborates with Celltrion for Anser Testing

Prometheus is the first specialty lab to validate TDM testing for both intravenous and subcutaneous infliximab, supporting the growing demand for at-home treatment options.

Clinical Trials | 28/08/2025 | By Dineshwori |  125

MMS Holdings, Friends of Cancer Research Partner to Develop Decision Frameworks for Interim Survival Data in Oncology Trials

MMS Holdings (MMS) has been selected by Friends of Cancer Research (Friends) to support the development of practical decision frameworks to inform the interpretation of interim overall survival (OS) data in oncology clinical trials.

Clinical Trials | 20/08/2025 | By Dineshwori |  145